Navigating Through New, First-Line Treatment Options for Lung Cancer.

doi:10.1200/JOP.18.00485

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Navigating Through New, First-Line Treatment Options for Lung Cancer.

Journal of oncology practice - 1 Sept 2018

Solomon Benjamin

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Carcinoma, Non-Small-Cell Lung
Share to Lung Neoplasms
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed

Identifiers

PMID: 30205774
DOI: 10.1200/JOP.18.00485

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Navigating Through New, First-Line Treatment Options for Lung Cancer.PMID 30205774Read ↗

Exploring the future of non-small cell lung cancer treatment.Semantic proximity Read ↗

Optimising therapy for EGFR-addicted NSCLC: just the start.Semantic proximity Read ↗

Tackling KRASG12C-mutated non-small-cell lung cancer: iteration and exploration.Semantic proximity Read ↗

Putting lung cancer clinical trials into perspective.Semantic proximity Read ↗

Difficulties on the access to innovative targeted therapies for lung cancer in Spain.Semantic proximity Read ↗

Postprogression Prolongation of Survival in EGFR-Mutated Lung Cancer: Reconciling the ASPIRATION and IMPRESS Trials.Semantic proximity Read ↗

Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A Review.Semantic proximity Read ↗

Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.